Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06570980 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

StatusUnknown
PhaseNot specified
Started2023-08-25
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 26, 2024 (before its estimated August 30, 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
Trial status changed: Recruiting → Unknown
The aim of this study is to compare the cost effectiveness of Sulfonylureas and DPP4-inhibitors in combination with Metformin among type2 diabetic patients diagnosed for 2-5 years. Glycemic status and other clinical outcome are compared in between two groups and ICER are compared.
Trial Details
NCT Number NCT06570980
Lead Sponsor Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin
Enrollment 200 participants
Start Date 2023-08-25
Primary Completion 2024-08-30 (estimated)
Study Completion 2024-08-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-26